Clinical Trials Logo

Clinical Trial Summary

The purpose of this multi-site randomized clinical study was to assess treatment outcomes for three forms of tinnitus treatment: Tinnitus Retraining Therapy (TRT), Tinnitus Masking, and Tinnitus Education (TED). There were four study sites: VAMC Audiology Clinics at Bay Pines, FL; Portland, OR; Seattle, WA; and San Diego, CA. Thirty-six subjects (Veterans) were enrolled into treatment at each site - 12 into each treatment group. Each subject received 18 months of treatment. Treatment appointments and outcome questionnaires occurred at 0, 3, 6, 12, and 18 months. Qualified subjects were initially randomized to one of the treatment groups or to a 6-month Waiting List group. Those in the Waiting List group completed outcome questionnaires at 3 and 6 months, and were randomized into one of the three treatment groups. They then received 18 months of treatment as above.


Clinical Trial Description

Although tinnitus is especially problematic for Veterans, the DVA has no established protocol for tinnitus rehabilitation. We recently completed a randomized clinical trial to evaluate the efficacy of tinnitus treatment for veterans. Tinnitus Masking and Tinnitus Retraining Therapy (TRT) were both shown to be effective for the majority of Veterans treated with these methods by expert tinnitus clinicians. The objective of the present study was to determine if the same level of treatment efficacy observed in the previous study could be obtained by typical VA audiologists in their clinical environment. In addition, a third group was added, called Tinnitus Education (TED), which served as a control group for nonspecific effects of treatment using a standardized protocol of hearing aids and education.

Veterans with clinically significant tinnitus were recruited to receive treatment with Masking, TRT, or TED in Audiology Clinics at the Bay Pines, Portland, San Diego, and Seattle VAMCs. There were three Treatment Audiologists at each of the sites, one for each of the three treatment methods. Each method uses a variation of sound therapy and of educational counseling. Sound therapy involves the use of wearable ear-level devices, including sound generators (maskers), hearing aids, or combination devices (hearing aid and masker combined). Only the TED group was restricted to the use of hearing aids only (note: TED subjects who did not require hearing aids were the only subjects in this study who did not receive ear-level devices). TRT uses a structured counseling protocol that teaches concepts that are unique to TRT. The Masking protocol has been created to match the TRT counseling with respect to comparable formatting and length of counseling sessions, but containing information specific to the concepts of Masking. The TED counseling protocol is similarly matched in format and length, but the information conveyed is of a more generic nature (general audiologic counseling information). Assessment of outcomes utilized questionnaires that were administered at intervals before, during, and after the 18 months of treatment.

Potential participants at all sites were telephone-screened by the Project Audiologist in Portland to determine if the tinnitus is a clinically significant problem warranting 18 months of treatment. Veterans who passed the screening were scheduled to meet with the Research Coordinator (RC) at the respective study site. At this first visit, Veterans were consented, completed questionnaires, and were then informed as to their group placement. Per a randomization schedule, they were placed into one of the three treatment groups, or into the 6-month waiting list group (with treatment starting 6 months later). At the initial evaluation with the respective Treatment Audiologist, a tinnitus verbal interview was administered, hearing and tinnitus testing were performed, and ear mold impressions were taken to order the custom ear-level devices. The Veteran returned approximately 3-4 weeks later to be fitted with the devices and to receive the counseling/education that initiates treatment. Subjects returned for follow-up treatment at 3, 6, 12 and 18 months. At the follow-up appointments, the RC collected and checked the questionnaires, and the Treatment Audiologist administered the follow-up verbal interview and repeated the counseling protocol. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00235807
Study type Interventional
Source VA Office of Research and Development
Contact
Status Completed
Phase N/A
Start date June 2004
Completion date November 2006

See also
  Status Clinical Trial Phase
Recruiting NCT05963542 - Efficacy of Online Acceptance and Commitment Therapy and Sound Therapy for Patients With Tinnitus and Insomnia N/A
Recruiting NCT04987502 - Virtual Reality and Subjective Tinnitus N/A
Recruiting NCT04404439 - Treatment of Tinnitus With Migraine Medications Phase 4
Recruiting NCT05533840 - Establishment and Application of a New Imaging System for Otology Based on Ultra-high Resolution CT
Completed NCT03552302 - Effects of Yoga Exercise on Participates With Tinnitus
Enrolling by invitation NCT02617953 - Objective Diagnosis Method and Efficacy of Repetitive Transcranial Magnetic Stimulation as a Treatment for Tinnitus N/A
Withdrawn NCT01663467 - Efficacy of Internet and Smartphone Application-delivered Tinnitus Retraining Therapy N/A
Completed NCT02974543 - Somatosensory Stimulation to Alleviate Tinnitus N/A
Completed NCT02269839 - A Feasibility Study Assessing the Effectiveness of rTMS in Tinnitus N/A
Completed NCT01929837 - Tinnitus rTMS 2013 N/A
Completed NCT01927991 - Internet-based Self-help for Tinnitus: The Role of Support N/A
Completed NCT01857661 - The Influence of the Sound Generator Combined With Conventional Amplification for Tinnitus Control: Blind Randomized Clinical Trial N/A
Terminated NCT01412918 - Inhibitor Masking Device & Sodium Channel, Voltage Gated, Type IX Alpha Subunit (SCN9) Gene Expression N/A
Completed NCT01480193 - New Therapy for Patients With Severe Tinnitus N/A
Completed NCT00371436 - Progressive Intervention Program for Tinnitus Management N/A
Completed NCT00748475 - Countering Stimulus-Induced Alpha-Desynchronization to Treat Tinnitus N/A
Completed NCT00733044 - Cost-effectiveness of Multidisciplinary Management of Tinnitus N/A
Active, not recruiting NCT05518682 - Assessment of Bimodal Stimulation Device Compliance and Satisfaction in Individuals With Tinnitus N/A
Recruiting NCT05212298 - Effects of Herbal Sleep Formula on Patients With Insomnia and Tinnitus N/A
Completed NCT06025097 - Intra-Tympanic Steroid With PRP Combination in Sensorineural Hearing Loss and Tinnitus. Early Phase 1